GenMark Roche Diagnostics Q1 Sales Climb 50 Percent The firm's diagnostics growth was driven by COVID-19 test sales with point-of-care sales skyrocketing year over year. GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month. Looking Beyond Pandemic, Roche Eyes Growing Opportunities for Dx Testing Premium Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally. Roche to Acquire GenMark Diagnostics for $1.8B Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share. Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Feb 26, 2021 GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission Premium Feb 25, 2021 GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales Feb 11, 2021 GenMark Shares Rise on Acquisition Rumors Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Jan 11, 2021 GenMark Diagnostics Preliminary Q4 Revenues Rise 84 Percent on ePlex Molecular Diagnostics Sales Oct 29, 2020 GenMark Diagnostics Expanding Manufacturing to Meet Pent Up Demand for SARS-CoV-2, Respiratory Panel Premium Oct 28, 2020 GenMark Q3 Revenues More Than Double on Respiratory Panel Sales Oct 8, 2020 GenMark Sees Jump in Preliminary Q3 Revenues, Nabs Respiratory Panel FDA Emergency Use Authorization Sep 14, 2020 GenMark Diagnostics Receives CE Mark for Respiratory Panel Including SARS-CoV-2, Flu Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 1, 2020 Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 4, 2020 GenMark Diagnostics Q2 Revenues More Than Double on COVID-19 Testing Jul 7, 2020 GenMark Diagnostics Preliminary Q2 Revenues Rise 118 Percent on SARS-CoV-2 Tests Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 1, 2020 Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details May 7, 2020 GenMark Diagnostics, Chembio Diagnostics Price Stock Offerings May 4, 2020 GenMark Diagnostics Q1 Revenues Grow 80 Percent May 1, 2020 GenomeWeb Index Recovers in April as Life Science Industry Focuses on Coronavirus Test Development Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.